Two Sigma Advisers LP acquired a new stake in shares of STERIS plc (NYSE:STE - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 45,547 shares of the medical equipment provider's stock, valued at approximately $9,363,000.
A number of other hedge funds also recently bought and sold shares of STE. Park Avenue Securities LLC lifted its stake in STERIS by 5.6% during the fourth quarter. Park Avenue Securities LLC now owns 2,369 shares of the medical equipment provider's stock valued at $487,000 after buying an additional 126 shares in the last quarter. Merit Financial Group LLC acquired a new position in shares of STERIS in the 4th quarter valued at about $260,000. Simon Quick Advisors LLC increased its holdings in shares of STERIS by 79.5% in the 4th quarter. Simon Quick Advisors LLC now owns 3,853 shares of the medical equipment provider's stock valued at $792,000 after purchasing an additional 1,707 shares during the period. SG Americas Securities LLC increased its holdings in shares of STERIS by 655.9% in the 4th quarter. SG Americas Securities LLC now owns 10,016 shares of the medical equipment provider's stock valued at $2,059,000 after purchasing an additional 8,691 shares during the period. Finally, Mutual Advisors LLC increased its holdings in shares of STERIS by 15.3% in the 4th quarter. Mutual Advisors LLC now owns 2,029 shares of the medical equipment provider's stock valued at $426,000 after purchasing an additional 269 shares during the period. 94.69% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on STE shares. JMP Securities upped their target price on STERIS from $265.00 to $280.00 and gave the company a "market outperform" rating in a report on Friday, May 16th. Stephens reiterated an "overweight" rating and issued a $250.00 target price on shares of STERIS in a report on Thursday, May 15th. Piper Sandler upped their target price on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Wall Street Zen upgraded STERIS from a "buy" rating to a "strong-buy" rating in a report on Thursday. Finally, Needham & Company LLC restated a "hold" rating on shares of STERIS in a report on Monday, April 7th. Two analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $264.00.
Check Out Our Latest Stock Analysis on STERIS
STERIS Trading Down 1.1%
NYSE:STE opened at $243.61 on Friday. The stock's 50 day moving average price is $225.95 and its 200 day moving average price is $220.00. STERIS plc has a 52 week low of $200.98 and a 52 week high of $252.79. The company has a market capitalization of $23.93 billion, a P/E ratio of 51.72 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13.
STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.59 by $0.15. The firm had revenue of $1.48 billion during the quarter, compared to analysts' expectations of $1.47 billion. STERIS had a return on equity of 13.91% and a net margin of 8.66%. The company's revenue was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.58 earnings per share. On average, research analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.
STERIS Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, June 26th. Shareholders of record on Tuesday, June 10th will be given a dividend of $0.57 per share. The ex-dividend date is Tuesday, June 10th. This represents a $2.28 dividend on an annualized basis and a yield of 0.94%. STERIS's payout ratio is currently 36.77%.
About STERIS
(
Free Report)
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Further Reading
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider STERIS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.
While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.